1 line
5.5 KiB
JSON
1 line
5.5 KiB
JSON
{"Activated partial thromboplastin time prolonged": 11.55304010966129, "Acute graft versus host disease in skin": 6.362211731247109, "Acute lymphocytic leukaemia": 90.54376377264838, "Acute lymphocytic leukaemia recurrent": 584.0499794171417, "Acute lymphocytic leukaemia refractory": 132.35339382448248, "Aphasia": 3.97509849087988, "Apraxia": 11.735727412449387, "Atelectasis": 4.00220821779747, "B precursor type acute leukaemia": 80.35453078541197, "B-cell aplasia": 3400.4029704541445, "B-cell type acute leukaemia": 203.59502564334872, "B-lymphocyte count abnormal": 1929.585872279043, "Bacteraemia": 4.141837613329832, "Blast cell count increased": 86.52630852031776, "Blood albumin decreased": 7.287499776215023, "Blood calcium decreased": 5.421222115419543, "Blood chloride increased": 10.89032492788458, "Blood fibrinogen decreased": 66.71422532841393, "Blood fibrinogen increased": 50.14012708155608, "Blood lactate dehydrogenase increased": 6.22835359434703, "Blood phosphorus decreased": 7.981567287742407, "Blood potassium decreased": 3.0609553439728923, "Blood pressure systolic decreased": 5.956464603966593, "Bone lesion": 14.103931280489345, "Bone marrow disorder": 11.097710664018605, "Bone marrow failure": 6.96689146524679, "Brain oedema": 3.950546775118291, "C-reactive protein decreased": 31.558231966858525, "C-reactive protein increased": 6.127000129911542, "Capillary leak syndrome": 25.71118295925762, "Carbon dioxide decreased": 21.223514497999616, "Central nervous system leukaemia": 89.18146417743372, "Central nervous system lymphoma": 26.42000969427001, "Clostridium difficile colitis": 5.132989245704502, "Coagulopathy": 18.811886412506823, "Congenital aplasia": 10.021218466821376, "Cytokine release syndrome": 586.2176351714313, "Cytokine storm": 35.87193091251117, "Cytomegalovirus infection": 3.52619971716912, "Cytopenia": 29.9609563353194, "Diffuse large B-cell lymphoma": 281.69919468589995, "Diffuse large B-cell lymphoma recurrent": 376.9993592030765, "Diffuse large B-cell lymphoma refractory": 125.3572413811146, "Disease progression": 2.1319660540186987, "Disease recurrence": 4.768185422539154, "Disorientation": 3.627609349416739, "Disseminated intravascular coagulation": 4.148602777615936, "Dysgraphia": 11.160270710439791, "Electrolyte imbalance": 2.997902569153828, "Encephalopathy": 6.515280847963993, "Enterococcal infection": 13.595702756095022, "Febrile neutropenia": 3.787204974713673, "Fibrin D dimer increased": 5.915109796147887, "Full blood count decreased": 11.05449778336716, "Graft versus host disease": 3.204861424632776, "Haematocrit decreased": 4.583176079809899, "Haemodynamic instability": 3.1639243104934165, "Haemoglobin decreased": 2.856055594230809, "Haemophagocytic lymphohistiocytosis": 39.15127894587606, "Hepatomegaly": 3.8070722932632046, "Hypervolaemia": 8.987968137474015, "Hypofibrinogenaemia": 57.89219235225119, "Hypogammaglobulinaemia": 140.2758781423761, "Hypotension": 6.106918295701565, "Hypoxia": 16.491645778492636, "Immune effector cell-associated neurotoxicity syndrome": 442.8114166519695, "Incontinence": 2.358406836584282, "Inflammatory marker increased": 7.161187893129215, "Interleukin level increased": 125.56499856297658, "Intracranial pressure increased": 3.5156190512935344, "Left ventricular dysfunction": 6.337394284218184, "Leukaemia recurrent": 10.81243580264405, "Localised oedema": 2.921036106234984, "Loss of CAR T-cell persistence": 1719.9631390808895, "Lymphocyte count decreased": 22.333219464869316, "Lymphoma": 7.175316025947196, "Lymphopenia": 2.6902697229658705, "Malignant neoplasm progression": 16.231291541400513, "Mean cell haemoglobin concentration increased": 63.47993213053206, "Mental status changes": 5.526766816122155, "Metastases to central nervous system": 2.8065009163255565, "Metastases to meninges": 17.4087257488375, "Minimal residual disease": 403.7936048847712, "Multiple organ dysfunction syndrome": 5.148071230720524, "Myelodysplastic syndrome": 5.44973197528824, "Nervous system disorder": 6.08858583728322, "Neurological decompensation": 19.10260970130401, "Neurotoxicity": 66.64143421379781, "Neutropenia": 2.9344232435118065, "Neutrophil count decreased": 4.987939989390185, "Non-Hodgkin's lymphoma": 8.82161451713208, "Oliguria": 4.218055009751324, "Optic neuritis": 2.4056935949643994, "Out of specification test results": 994.662270761931, "Oxygen saturation decreased": 3.050256533805608, "Pancytopenia": 6.835060632109216, "Platelet count decreased": 4.198761806161137, "Pleural effusion": 2.0654266895904483, "Pneumonia fungal": 7.032640355274652, "Post-depletion B-cell recovery": 14899.032451876572, "Protein total decreased": 9.225437549353147, "Prothrombin time prolonged": 7.042070123370153, "Pyrexia": 2.6153469476510223, "Red blood cell count decreased": 5.592592327324308, "Red cell distribution width increased": 9.114433446266275, "Remission not achieved": 95.7618000705373, "Respiratory rate increased": 3.822219750053017, "Second primary malignancy": 20.21401009052694, "Septic shock": 3.3417569749010974, "Serum ferritin increased": 65.39416401357049, "T-cell lymphoma": 33.08506731837743, "Tachycardia": 2.503839111525984, "Tachypnoea": 7.786120482614289, "Therapeutic product effect incomplete": 4.7445036753695, "Therapy non-responder": 5.525414209116877, "Therapy partial responder": 4.801821557044752, "Thrombocytopenia": 2.278906418477689, "Transformation to acute myeloid leukaemia": 77.33313869724412, "Tumour lysis syndrome": 10.239030383835916, "White blood cell count decreased": 2.96821724130266, "White blood cell count increased": 2.604793675326871} |